+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Rotavirus Vaccine Market - Global Forecast 2025-2030- Product Image
Rotavirus Vaccine Market - Global Forecast 2025-2030- Product Image
Sale

Rotavirus Vaccine Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6123524
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global rotavirus vaccine market is evolving rapidly as new formulations and emerging public health strategies reshape immunization efforts. Market participants must navigate shifting demand patterns, regulatory changes, and dynamic supply chains for sustained growth and meaningful public health impact.

Market Snapshot

The rotavirus vaccine market reflects ongoing international investment in pediatric disease prevention and healthcare infrastructure. Recent years have seen measurable improvements in vaccine-driven reductions of pediatric diarrheal disease. Vaccines are increasingly prioritized by governments, with adjustments in procurement models and broader immunization efforts now observed across developed and emerging regions. Leading industry players continue to enhance immunization coverage through manufacturing advancements, alliances with procurement agencies, and regional partnerships. Technology integration—such as digital tracking and advanced cold chain systems—further supports efficient vaccine administration and monitoring.

Scope & Segmentation

This report offers thorough coverage of the rotavirus vaccine market, outlining essential segmentation and regional dynamics:

  • Vaccine Types: Inactivated; Live Attenuated Oral
  • Distribution Channels: Clinics; Hospital Pharmacies; Online Pharmacies; Retail Pharmacies
  • End Users: General Clinics; Pediatric Clinics; Community Health Centers (Hospital-Based, Standalone); Private Hospitals; Public Hospitals
  • Presentation Formats: Liquid (Multi-dose Vials, Prefilled Syringes); Lyophilized (Multi-dose Vials, Single-dose Vials)
  • Regions Covered: Americas (including United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland); Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies Profiled: Merck & Co., Inc.; GlaxoSmithKline plc; Bharat Biotech International Limited; Serum Institute of India Pvt. Ltd.; Chengdu Institute of Biological Products Co., Ltd.; Lanzhou Institute of Biological Products Co., Ltd.; Wuhan Institute of Biological Products Co., Ltd.; Beijing Institute of Biological Products Co., Ltd.; Institute of Medical Biology, Chinese Academy of Medical Sciences

Key Takeaways

  • Rotavirus vaccines are integral to global pediatric health strategies due to their impact on severe diarrheal illnesses and healthcare burden reduction.
  • Innovative vaccine designs now include non-live formulations and adjuvant-enhanced candidates, broadened by the exploration of combination immunization schedules for greater efficiency.
  • Policy coordination—supported by alliances among national authorities, international organizations, and private partners—enables sustainable procurement and enhances cost management, particularly in lower-resource settings.
  • Digital health platforms, advanced cold chain technologies, and real-time tracking strengthen vaccine deployment and help address disparities in remote or underserved communities.
  • Manufacturing excellence and strategic collaborations—between globally established companies and regional innovators—drive supply resilience, localized production, and technology transfer, ensuring greater market accessibility.

Tariff Impact on the Rotavirus Vaccine Market

Recent changes in United States tariff schedules are influencing supply chain structures and cost management strategies in the rotavirus vaccine market. Manufacturers are diversifying suppliers and exploring regional sourcing to reduce tariff exposure. Strategic procurement initiatives, including long-term vendor contracts and investments in localized production, are key responses to manage and mitigate additional duties on raw materials and essential components.

Methodology & Data Sources

This analysis is built on a multi-source research approach, combining rigorous literature review, regulatory filings, and primary input from sector experts. Stakeholder interviews and site observations validated operational and supply chain frameworks. Quality assurance included expert consultations and methodological audits to ensure insight reliability and accuracy.

Why This Report Matters

  • Enables strategic planning by mapping evolving regulatory, scientific, and operational trends in the rotavirus vaccine market.
  • Supports investment and resource allocation decisions through actionable segmentation and regional insights tailored to senior executive needs.
  • Guides supply chain and procurement leaders in adapting to changing cost structures and leveraging new technologies for efficient vaccine delivery.

Conclusion

Transformative scientific advances, coordinated policy actions, and technology integration are shifting the rotavirus vaccine landscape. Market participants will benefit from a focused, data-driven approach to optimize strategy, access, and impact in an increasingly complex environment.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of public-private partnerships to scale up rotavirus vaccine production and distribution in low-income countries
5.2. Increasing focus on thermostable formulation development to reduce cold chain dependency in rotavirus vaccine delivery
5.3. Emerging competition from oral next-generation live attenuated vaccines with enhanced genotype coverage profiles
5.4. Integration of rotavirus immunization tracking into digital health ecosystems for real-time coverage analytics
5.5. Impact of fluctuating Gavi funding commitments on rotavirus vaccine affordability and national immunization plans
5.6. Advancements in injectable rotavirus vaccine candidates targeting mucosal immunity with reduced dosing schedules
5.7. Expansion of regional manufacturing hubs aimed at reducing supply chain bottlenecks in rotavirus vaccine access
5.8. Use of real-world evidence from low-resource settings to refine rotavirus vaccine dosing recommendations and schedules
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Rotavirus Vaccine Market, by Vaccine Type
8.1. Introduction
8.2. Inactivated
8.3. Live Attenuated Oral
9. Rotavirus Vaccine Market, by Distribution Channel
9.1. Introduction
9.2. Clinics
9.3. Hospital Pharmacies
9.4. Online Pharmacies
9.5. Retail Pharmacies
10. Rotavirus Vaccine Market, by End User
10.1. Introduction
10.2. Clinics
10.2.1. General Clinics
10.2.2. Pediatric Clinics
10.3. Community Health Centers
10.3.1. Hospital Based
10.3.2. Standalone
10.4. Hospitals
10.4.1. Private Hospitals
10.4.2. Public Hospitals
11. Rotavirus Vaccine Market, by Presentation
11.1. Introduction
11.2. Liquid
11.2.1. Multi-dose Vial
11.2.2. Prefilled Syringes
11.3. Lyophilized
11.3.1. Multi-dose Vial
11.3.2. Single-dose Vial
12. Americas Rotavirus Vaccine Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Rotavirus Vaccine Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Rotavirus Vaccine Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Merck & Co., Inc.
15.3.2. GlaxoSmithKline plc
15.3.3. Bharat Biotech International Limited
15.3.4. Serum Institute of India Pvt. Ltd.
15.3.5. Chengdu Institute of Biological Products Co., Ltd.
15.3.6. Lanzhou Institute of Biological Products Co., Ltd.
15.3.7. Wuhan Institute of Biological Products Co., Ltd.
15.3.8. Beijing Institute of Biological Products Co., Ltd.
15.3.9. Institute of Medical Biology, Chinese Academy of Medical Sciences
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ROTAVIRUS VACCINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ROTAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS ROTAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ROTAVIRUS VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES ROTAVIRUS VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ROTAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ROTAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ROTAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ROTAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ROTAVIRUS VACCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. ROTAVIRUS VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. ROTAVIRUS VACCINE MARKET: RESEARCHAI
FIGURE 24. ROTAVIRUS VACCINE MARKET: RESEARCHSTATISTICS
FIGURE 25. ROTAVIRUS VACCINE MARKET: RESEARCHCONTACTS
FIGURE 26. ROTAVIRUS VACCINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ROTAVIRUS VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY INACTIVATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY LIVE ATTENUATED ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY LIVE ATTENUATED ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY PEDIATRIC CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY PEDIATRIC CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITAL BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITAL BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY STANDALONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY STANDALONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY MULTI-DOSE VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY MULTI-DOSE VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY MULTI-DOSE VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY MULTI-DOSE VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY SINGLE-DOSE VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY SINGLE-DOSE VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ROTAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ROTAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES ROTAVIRUS VACCINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES ROTAVIRUS VACCINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 109. CANADA ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 110. CANADA ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 111. CANADA ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. CANADA ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. CANADA ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. CANADA ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. CANADA ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 116. CANADA ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 117. CANADA ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2018-2024 (USD MILLION)
TABLE 118. CANADA ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2025-2030 (USD MILLION)
TABLE 119. CANADA ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 120. CANADA ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 121. CANADA ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 122. CANADA ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 123. CANADA ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 124. CANADA ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 125. CANADA ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2018-2024 (USD MILLION)
TABLE 126. CANADA ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2025-2030 (USD MILLION)
TABLE 127. MEXICO ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 128. MEXICO ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 129. MEXICO ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. MEXICO ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. MEXICO ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. MEXICO ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. MEXICO ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 134. MEXICO ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 135. MEXICO ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2018-2024 (USD MILLION)
TABLE 136. MEXICO ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2025-2030 (USD MILLION)
TABLE 137. MEXICO ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 138. MEXICO ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 139. MEXICO ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 140. MEXICO ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 141. MEXICO ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 142. MEXICO ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 143. MEXICO ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2018-2024 (USD MILLION)
TABLE 144. MEXICO ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA ROTAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA ROTAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2025-2030 (USD MILLION)
TABLE 219. GERMANY ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 220. GERMANY ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 221. GERMANY ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. GERMANY ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. GERMANY ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. GERMANY ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. GERMANY ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 226. GERMANY ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 227. GERMANY ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2018-2024 (USD MILLION)
TABLE 228. GERMANY ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2025-2030 (USD MILLION)
TABLE 229. GERMANY ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 230. GERMANY ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 231. GERMANY ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 232. GERMANY ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 233. GERMANY ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 234. GERMANY ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 235. GERMANY ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2018-2024 (USD MILLION)
TABLE 236. GERMANY ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2025-2030 (USD MILLION)
TABLE 237. FRANCE ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 238. FRANCE ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 239. FRANCE ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. FRANCE ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. FRANCE ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. FRANCE ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. FRANCE ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 244. FRANCE ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 245. FRANCE ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2018-2024 (USD MILLION)
TABLE 246. FRANCE ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2025-2030 (USD MILLION)
TABLE 247. FRANCE ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 248. FRANCE ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 249. FRANCE ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 250. FRANCE ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 251. FRANCE ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 252. FRANCE ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 253. FRANCE ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2018-2024 (USD MILLION)
TABLE 254. FRANCE ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2025-2030 (USD MILLION)
TABLE 273. ITALY ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 274. ITALY ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 275. ITALY ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. ITALY ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. ITALY ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. ITALY ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. ITALY ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 280. ITALY ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 281. ITALY ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2018-2024 (USD MILLION)
TABLE 282. ITALY ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2025-2030 (USD MILLION)
TABLE 283. ITALY ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 284. ITALY ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 285. ITALY ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 286. ITALY ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 287. ITALY ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 288. ITALY ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 289. ITALY ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2018-2024 (USD MILLION)
TABLE 290. ITALY ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2025-2030 (USD MILLION)
TABLE 291. SPAIN ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 292. SPAIN ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 293. SPAIN ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. SPAIN ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. SPAIN ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. SPAIN ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. SPAIN ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 298. SPAIN ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 299. SPAIN ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2018-2024 (USD MILLION)
TABLE 300. SPAIN ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2025-2030 (USD MILLION)
TABLE 301. SPAIN ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 302. SPAIN ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 303. SPAIN ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 304. SPAIN ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 305. SPAIN ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 306. SPAIN ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 307. SPAIN ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2018-2024 (USD MILLION)
TABLE 308. SPAIN ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2025-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2018-2024 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2025-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2018-2024 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2025-2030 (USD MILLION)
TABLE 327. SAUDI ARABIA ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 328. SAUDI ARABIA ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 329. SAUDI ARABIA ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 330. SAUDI ARABIA ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 331. SAUDI ARABIA ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 332. SAUDI ARABIA ROTAVIRUS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 333. SAUDI ARABIA ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 334. SAUDI ARABIA ROTAVIRUS VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 335. SAUDI ARABIA ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2018-2024 (USD MILLION)
TABLE 336. SAUDI ARABIA ROTAVIRUS VACCINE MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2025-2030 (USD MILLION)
TABLE 337. SAUDI ARABIA ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 338. SAUDI ARABIA ROTAVIRUS VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 339. SAUDI ARABIA ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 340. SAUDI ARABIA ROTAVIRUS VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 341. SAUDI ARABIA ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 342. SAUDI ARABIA ROTAVIRUS VACCINE MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 343. SAUDI ARABIA ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2018-2024 (USD MILLION)
TABLE 344. SAUDI ARABIA ROTAVIRUS VACCINE MARKET SIZE, BY LYOPHILIZED, 2025-2030 (USD MILLION)
TABLE 345. SOUTH AFRICA ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 346. SOUTH AFRICA ROTAVIRUS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 347. SOUTH AFRICA ROTAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 348. SOUTH A

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Rotavirus Vaccine market report include:
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Bharat Biotech International Limited
  • Serum Institute of India Pvt. Ltd.
  • Chengdu Institute of Biological Products Co., Ltd.
  • Lanzhou Institute of Biological Products Co., Ltd.
  • Wuhan Institute of Biological Products Co., Ltd.
  • Beijing Institute of Biological Products Co., Ltd.
  • Institute of Medical Biology, Chinese Academy of Medical Sciences

Related Topics

Related Reports

Multivalent Oral Rotavirus Vaccine Market - Global Forecast 2025-2030 - Product Image

Multivalent Oral Rotavirus Vaccine Market - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Rotavirus Vaccines - Global Strategic Business Report - Product Image

Rotavirus Vaccines - Global Strategic Business Report

  • Report
  • 277 Pages
  • Global
From
Rotavirus Vaccine Market Report 2025 - Product Image

Rotavirus Vaccine Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Rotavirus Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Rotavirus Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Rotavirus Prophylaxis Market Report 2025 - Product Image

Rotavirus Prophylaxis Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.